Bottom-line, we raised more co-invest than we expected this year, and while that impacted our ability to achieve our FRE targets based on timing ... we have a bespoke SMA that's at our discretion ...

The evolution of functional assessments for spinal muscular atrophy (SMA) highlights the challenges of adapting pediatric ...

Scientists report results from a promising new approach to treat the rare neurodegenerative disorder. Spinal muscular atrophy (SMA) is a progressive neurodegenerative disorder set in motion before ...

European Union trade chief Maros Sefcovic said on Thursday that his top priority in trade talks with President Donald Trump's ...

Poland-based Clone Robotics designed the Protoclone ... The Protoclone reportedly contains over 1,000 artificial muscles built with the company's "Myofiber" technology, which builds on the ...

AI-powered voice recognition software is helping my career as a journalist and my studies, but it's not without risks.

The US Food and Drug Administration has approved a new drug application for a tablet version of Evrysdi (risdiplam) for people living with spinal muscular atrophy (SMA).

Startups from outside the UK are also contributing. Denmark’s Pliantics will create soft linear actuators, which will serve ...

Its muscles are composed of Clone's proprietary "Myofiber" artificial muscle tech, providing an unparalleled combination of "weight, power density, speed, force-to-weight, and energy efficiency ...

Artificial intelligence makes humanoid robotics possible, which could be a $38 billion market by 2035. The internet was a groundbreaking innovation that created new markets and opportunities.